Latest News


October 6, 2021

A selective antibiotic for Lyme disease

Nadja Leimer, Xiaoqian Wu, Yu Imai, Linden T. Hu, Helen I. Zgurskaya, Kim Lewis

October 1, 2020

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney

November 16, 2009

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi

By Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ


Chronic Lyme Disease Is Getting Its Moment


Genetic Variant Increases Susceptibility to Lyme Disease


Duke University May Awareness Guest Blog – Lyme Disease Advocacy Project Update


Memorandum Regarding the Relationship Between the Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists


Lyme Disease Association, Inc. Presents A May Lyme Disease Awareness Program: National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People With a Focus on Lyme & Ticks


National Community Engagement Initiative Meeting Scheduled for TBDs